D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Pfizer
PFE
|
+$439M |
| 2 |
AbbVie
ABBV
|
+$401M |
| 3 |
Johnson & Johnson
JNJ
|
+$308M |
| 4 |
Gilead Sciences
GILD
|
+$261M |
| 5 |
Mercado Libre
MELI
|
+$259M |
Top Sells
| 1 |
Booking.com
BKNG
|
+$391M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$390M |
| 3 |
Citigroup
C
|
+$315M |
| 4 |
PayPal
PYPL
|
+$282M |
| 5 |
SHPG
Shire pic
SHPG
|
+$276M |
Sector Composition
| 1 | Technology | 20.75% |
| 2 | Consumer Discretionary | 16.79% |
| 3 | Healthcare | 16.62% |
| 4 | Financials | 9.01% |
| 5 | Industrials | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
376
VF Corp
VFC
$5.87B
| $33.8M | 0.04% |
413,369
+397,203
| +2,457% | +$32.5M |
|
377
Trane Technologies
TT
$92.8B
| $33.6M | 0.04% |
311,517
-26,270
| -8% | -$2.84M |
|
378
HCA Healthcare
HCA
$92.2B
| $33.6M | 0.04% |
257,899
+15,846
| +7% | +$2.07M |
|
379
Genuine Parts
GPC
$19.3B
| $33.6M | 0.04% |
300,026
+180,082
| +150% | +$20.2M |
|
380
Avista
AVA
$2.92B
| $33.4M | 0.04% |
822,700
+566,659
| +221% | +$23M |
|
381
PTC Therapeutics
PTCT
$4.65B
| $33.2M | 0.04% |
882,636
-113,434
| -11% | -$4.27M |
|
382
Tandem Diabetes Care
TNDM
$837M
| $33M | 0.04% |
519,524
+483,553
| +1,344% | +$30.7M |
|
|
HMSY
383
DELISTED
HMS Holdings Corp.
HMSY
| $32.9M | 0.04% |
1,111,822
+136,971
| +14% | +$4.06M |
|
|
CFXA
384
DELISTED
Colfax Corporation 5.75% Tangible Equity Units
CFXA
| $32.7M | 0.04% |
+245,000
| New | +$32.7M |
|
|
KL
385
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $32.4M | 0.04% |
1,063,779
+81,499
| +8% | +$2.48M |
|
386
Navient
NAVI
$1.31B
| $32.3M | 0.04% |
2,791,886
-1,254,582
| -31% | -$14.5M |
|
387
United Therapeutics
UTHR
$18B
| $32.3M | 0.04% |
275,073
-162,003
| -37% | -$19M |
|
388
Sealed Air
SEE
$4.83B
| $32.2M | 0.04% |
698,039
-286,187
| -29% | -$13.2M |
|
389
TC Energy
TRP
$54B
| $32.1M | 0.04% |
714,913
-1,102,020
| -61% | -$49.5M |
|
|
EVBG
390
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $32.1M | 0.04% |
427,930
+352,902
| +470% | +$26.5M |
|
|
DYNC
391
DELISTED
Vistra Energy Corp.
DYNC
| $32.1M | 0.04% |
+325,000
| New | +$32.1M |
|
392
Evergy
EVRG
$16.4B
| $32M | 0.04% |
550,941
-110,751
| -17% | -$6.43M |
|
|
ZEN
393
DELISTED
ZENDESK INC
ZEN
| $31.8M | 0.04% |
374,592
-164,927
| -31% | -$14M |
|
394
Autodesk
ADSK
$68.8B
| $31.7M | 0.04% |
203,174
+4,050
| +2% | +$631K |
|
395
NovoCure
NVCR
$1.37B
| $31.6M | 0.04% |
656,881
+614,012
| +1,432% | +$29.6M |
|
396
Treehouse Foods
THS
$877M
| $31.6M | 0.04% |
489,375
+179,057
| +58% | +$11.6M |
|
397
BHP
BHP
$135B
| $31.4M | 0.04% |
644,381
-822,148
| -56% | -$40.1M |
|
|
MNTA
398
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $31.2M | 0.04% |
2,148,849
-449,793
| -17% | -$6.54M |
|
|
CATM
399
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
| $31.2M | 0.04% |
876,174
+174,919
| +25% | +$6.22M |
|
400
DNOW Inc
DNOW
$1.63B
| $31.1M | 0.04% |
2,226,959
-42,164
| -2% | -$589K |
|